🇺🇸 FDA
Patent

US 12297243

Methods and compositions for reducing the immunogenicity of chimeric notch receptors

granted A61KA61K2039/5156A61K48/00

Quick answer

US patent 12297243 (Methods and compositions for reducing the immunogenicity of chimeric notch receptors) held by Cell Design Labs, Inc. expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cell Design Labs, Inc.
Grant date
Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/5156, A61K48/00, A61P, A61P35/00